Status
Conditions
Treatments
About
FINISH-trial is a prospective, randomized, controlled, parallel group non-inferiority trial comparing single burr-hole evacuation of chronic subdural hematoma (CSDH) with intraoperative irrigation (IR) and evacuation of CSDH without irrigation (N-IR).
Full description
FINISH-trial is a prospective, randomized, controlled, parallel group non-inferiority trial comparing single burr-hole evacuation of chronic subdural hematoma (CSDH) with intraoperative irrigation (IR) and evacuation of CSDH without irrigation (N-IR). In both groups, a passive subdural drain is used for 48 hours as a standard of treatment. The study will be conducted in all five neurosurgical departments in Finland. To determine whether operation without irrigation results in non-inferior outcome to operation with irrigation, we will randomize 426 patients into two groups and follow them up for 6 months using recurrence rates as the primary outcome. Secondary outcomes in our study include mortality, neurological outcome and complications.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with a symptomatic unilateral or bilateral CSDH requiring burr-hole evacuation
o Predominantly hypodense or isodense on imaging (CT/MRI).
Clinical symptoms correlating with the CSDH
Patients with bilaterally operated CSDHs will be treated with the same protocol on both sides and analyzed as a single study participant
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
587 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal